Collaborating with Risk-Taking Oncologists: Unlocking Innovative Cancer Treatment Strategies

Navigating Hope in Pancreatic Cancer Treatment: A Personal Journey

In May 2014, at the age of 60, I was confronted with a life-altering diagnosis of stage IV pancreatic cancer. The news hit hard—my doctors suggested I had just a year to live. Until that moment, I had shown no symptoms; it was merely the onset of jaundice that led me to seek medical advice. The shock rippled through my family as we began exploring treatment options, hoping for a ray of hope amidst the darkness.

Seeking Alternative Treatment Approaches

After my initial consultation with an oncologist who recommended the aggressive FOLFIRINOX regimen, I felt compelled to seek a second opinion. This led me to Dr. William Isacoff, a prominent oncologist in Los Angeles, whose innovative approach to chemotherapy piqued my interest. He proposed a slow dosing regimen, arguing that this strategy could effectively target the tumor while minimizing side effects, allowing me to maintain a better quality of life. My treatment began in June 2014, under the guidance of both Dr. Isacoff and Dr. Allyson Ocean at NewYork-Presbyterian Hospital/Weill Cornell.

Innovative Treatment Protocols and Research

My treatment plan included a combination of Abraxane, oxaliplatin, leucovorin, Avastin, and 5-FU, delivered via a pump over two weeks. Over the subsequent years, my treatment evolved based on the latest research. Dr. Mark Ricigliano developed a groundbreaking method to analyze circulating tumor cells through a simple blood test, allowing my oncologists to tailor my medications according to the tumor’s changing sensitivities.

• Current Medications: Gemzar, cisplatin, mitomycin C, and Xeloda
• Additional Treatment: Synthetic vitamin D, based on Dr. Ron Evans’ promising research at the Salk Institute

While the clinical trials for vitamin D are ongoing, my doctors believe its use poses no significant risks, adding another layer of hope to my treatment.

A Journey of Resilience and Gratitude

As I approach the two-year mark since my diagnosis, I feel grateful for the exceptional care and innovative approaches from my medical team. Their willingness to explore new scientific avenues has significantly impacted my journey, allowing me to live a fulfilling life despite the challenges of pancreatic cancer.

I am determined to share my story to inspire others facing similar battles, emphasizing the importance of seeking second opinions and remaining open to new treatment possibilities.

In Memory of Anne Glauber

Anne’s battle with pancreatic cancer was a testament to her resilience and determination. Her legacy continues to inspire those affected by this disease through initiatives like Let’s Win, dedicated to supporting patients, caregivers, and researchers in the fight against pancreatic cancer. For more insights into personalized treatment options and innovative therapies, consider exploring resources on personalizing pancreatic cancer treatment and low-dose chemotherapy strategies.